Berkshire Hathaway After Q3: Where Buffett Is Deploying Cash — Insurance Float, Buybacks and the Portfolio’s Quiet Rotations
Warren Buffett’s Berkshire Hathaway headed into the year’s final stretch with its operating engine revving, its cash stack at a fresh record and its capital allocation stance unmistakably cautious. Operating earnings surged on the back of a resurgent insurance franchise, yet management eschewed share repurchases, trimmed public equity exposure and inked just one major deal — a cash acquisition of Occidental’s petrochemical arm, OxyChem. Investors are digesting this against an unusual backdrop: a second consecutive Federal Reserve rate cut heading into December’s meeting, lingering inflation and tariff pressures, and a leadership handoff to Greg Abel at year-end with Buffett staying on as chair. The through line is discipline — a high bar for buybacks, a preference for control transactions in cash-generative businesses, and a willingness to let record liquidity earn respectable yields while waiting for volatility to reset prices. Here’s where Berkshire stands after the third quarter and how the macro fog and the Abel era could shape the next phase of deployment.